These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 33497729)

  • 21. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-
    Anjum FR; Anam S; Abbas G; Mahmood MS; Rahman SU; Goraya MU; Abdullah RM; Luqman M; Ali A; Akram MK; Chaudhry TH
    Viral Immunol; 2021 Jun; 34(5):321-329. PubMed ID: 33181057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of selected Nigerian tropical plants in the treatment of COVID-19: in silico and in vitro investigations.
    Oladele JO; Adewole TS; Ogundepo GE; Oyeleke OM; Kuku A
    Environ Sci Pollut Res Int; 2022 Dec; 29(59):89295-89339. PubMed ID: 35849237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of phytoconstituents in the management of COVID-19.
    Das A; Pandita D; Jain GK; Agarwal P; Grewal AS; Khar RK; Lather V
    Chem Biol Interact; 2021 May; 341():109449. PubMed ID: 33798507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review: An insight into coronaviruses: Challenges, security and scope.
    Shah N; Davariya V; Gupta SK; Gajjar P; Parmar J; D'Cruz L
    Rev Med Virol; 2020 Nov; 30(6):1-8. PubMed ID: 32754974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Attention towards the Prophylactic and Therapeutic Options of Phytochemicals for SARS-CoV-2: A Molecular Insight.
    Shoaib S; Ansari MA; Kandasamy G; Vasudevan R; Hani U; Chauhan W; Alhumaidi MS; Altammar KA; Azmi S; Ahmad W; Wahab S; Islam N
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery.
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(7):571-596. PubMed ID: 33463470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying Inhibitors of -1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses.
    Munshi S; Neupane K; Ileperuma SM; Halma MTJ; Kelly JA; Halpern CF; Dinman JD; Loerch S; Woodside MT
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects.
    Jamshidnia M; Sewell RDE; Rafieian-Kopaei M
    Curr Pharm Des; 2022; 28(29):2415-2425. PubMed ID: 35899955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Updated Review on SARS-CoV-2 Main Proteinase (M
    Sabbah DA; Hajjo R; Bardaweel SK; Zhong HA
    Curr Top Med Chem; 2021; 21(6):442-460. PubMed ID: 33292134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Programmed -1 Ribosomal Frameshifting in coronaviruses: A therapeutic target.
    Kelly JA; Woodside MT; Dinman JD
    Virology; 2021 Feb; 554():75-82. PubMed ID: 33387787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections.
    Tong TR
    Infect Disord Drug Targets; 2009 Apr; 9(2):223-45. PubMed ID: 19275708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
    Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
    Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral applications of RNAi for coronavirus.
    Wu CJ; Chan YL
    Expert Opin Investig Drugs; 2006 Feb; 15(2):89-97. PubMed ID: 16433589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.
    Smith EC; Blanc H; Surdel MC; Vignuzzi M; Denison MR
    PLoS Pathog; 2013 Aug; 9(8):e1003565. PubMed ID: 23966862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective Antiviral Medicinal Plants and Biological Compounds Against Central Nervous System Infections: A Mechanistic Review.
    Malekmohammad K; Rafieian-Kopaei M; Sardari S; Sewell RDE
    Curr Drug Discov Technol; 2020; 17(4):469-483. PubMed ID: 31309894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral effects of phytochemicals against severe acute respiratory syndrome coronavirus 2 and their mechanisms of action: A review.
    Jantan I; Arshad L; Septama AW; Haque MA; Mohamed-Hussein ZA; Govender NT
    Phytother Res; 2023 Mar; 37(3):1036-1056. PubMed ID: 36343627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data.
    Islam MT; Sarkar C; El-Kersh DM; Jamaddar S; Uddin SJ; Shilpi JA; Mubarak MS
    Phytother Res; 2020 Oct; 34(10):2471-2492. PubMed ID: 32248575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.